BioMarin Pharma (BMRN) Misses Q4 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. PRY:IM
5. PRYMY

6. SKA-B
7. PBA
8. CCH:LN
9. META
10. CCHGY

Get Alerts BMRN Hot Sheet

Price: $58.99 +2.02%

Revenue Growth %: +13.2%

Financial Fact:
INCOME FROM OPERATIONS: -60.09M

Today's EPS Names:
CRMT, More

Join SI Premium – FREE

BioMarin Pharma (NASDAQ: BMRN) reported Q4 EPS of ($0.30), $0.07 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $358.3 million versus the consensus estimate of $351.62 million.

GUIDANCE:

BioMarin Pharma sees FY2018 revenue of $1.47-1.53 billion, versus the consensus of $1.48 billion.

For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

Create E-mail Alert Related Categories

Earnings, Guidance

Related Entities

Earnings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!